1. GlaxoSmithKline A multicenter, double-blind, placebo-controlled comparison of Carvedilol (SK&F) 6.25 mg, 12.5 mg, and 25.0 mg administered twice daily in patients with mild and moderate hypertension. http://www.gsk-clinicalstudyregister.com/result_detail.jsp?protocolId=105517%2F021&studyId=80A0B2AA-C084-4ACF-8FA7-23C564527CF2&compound=carvedilol (accessed - day month year)
2. GlaxoSmithKline A multicenter, double-blind, placebo-controlled comparison of carvedilol (SK&F 105517) 6.25mg, 12.5mg, 25mg, and 50mg administered once daily in patients with mild to moderate hypertension. http://www.gsk-clinicalstudyregister.com/result_detail.jsp?protocolId=105517%2F022&studyId=CD325C8A-3EBC-4621-91DE-C403E8D28CFD&compound=carvedilol (accessed day month year )
3. Combined alpha- and beta-adrenoceptor blockade with labetalol in hypertension;Frick;British Medical Journal,1976
4. A double blind trial of labetalol;Kane;British Journal of Clinical Pharmacology,1976
5. Clinical evaluation of labetalol alone and combined with chlorthalidone in essential hypertension: a double blind multicenter controlled study;Lechi;European Journal of Clinical Pharmacology,1982